1. Tsuchiya H, Morishita H, Tomita K, Ueda Y, Tanaka M (1993) Differentiating and antitumor activities of 1α, 25-dihydroxyvitamin D3 in vitro and 1 α-hydroxyvitamin D3 in vivo on human osteosarcoma. J Orthop Res 11:122–130
2. Testa U, Masciulli R, Tritarelli E, Pustorino R, Mariani G, Martucci R, Barberi T, Camagna A, Valtieri M, Peschle C (1993) Transforming growth factor-ß potentiates vitamin D3-induced terminal monocytic differentiation of human leukemic cell lines. J Immunol 150:2418–2430
3. Eisman JA, Barkla DH, Tutton PJ (1987) Suppression of in vivo growth of human cancer solid tumor xenografts by 1, 25-dihydroxyvitamin D3. Cancer Res 47:21–25
4. Chung I, Wong MK, Flynn G, Yu WD, Johnson CS, Trump DL (2006) Differential antiproliferative effects of calcitriol on tumor-derived and matrigel-derived endothelial cells. Cancer Res 66:8565–8573
5. Hershberger PA, Modzelewski RA, Shurin ZR, Rueger RM, Trump DL, Johnson CS (1999) 1, 25-dihydroxycholecalciferal (1, 25–D3) inhibits the growth of squamous cell carcinoma and down-modulates p21 (waf1/Cip1) in vitro and in vivo. Cancer Res 59:2644–2649